Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

Asokan, 2012, The AAV vector toolkit: poised at the clinical crossroads, Mol Ther, 20, 699, 10.1038/mt.2011.287 Foust, 2009, Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes, Nat Biotechnol, 27, 59, 10.1038/nbt.1515 Yang, 2014, Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10, Mol Ther, 22, 1299, 10.1038/mt.2014.68 Girod, 1999, Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2, Nat Med, 5, 1438, 10.1038/71021 Grifman, 2001, Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids, Mol Ther, 3, 964, 10.1006/mthe.2001.0345 Nicklin, 2001, Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells, Mol Ther, 4, 174, 10.1006/mthe.2001.0424 Chen, 2009, Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy, Nat Med, 15, 1215, 10.1038/nm.2025 Sleat, 2004, A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration, J Neurosci, 24, 9117, 10.1523/JNEUROSCI.2729-04.2004 Sleat, 1997, Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis, Science, 277, 1802, 10.1126/science.277.5333.1802 Balestrieri, 2007, Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors, Eur J Cancer, 43, 1242, 10.1016/j.ejca.2007.02.006 Rajotte, 1999, Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display, J Biol Chem., 274, 11593, 10.1074/jbc.274.17.11593 Daquinag, 2011, An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells, Cell Stem Cell, 9, 74, 10.1016/j.stem.2011.05.017 Brown, 2007, Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells, Brain Res., 1130, 17, 10.1016/j.brainres.2006.10.083 Montesano, 1990, Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene, Cell, 62, 435, 10.1016/0092-8674(90)90009-4 Kaludov, 2001, Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity, J Virol, 75, 6884, 10.1128/JVI.75.15.6884-6893.2001 Wu, 2006, Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6, J Virol, 80, 9093, 10.1128/JVI.00895-06 Robertson, 1978, Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells, Cell, 13, 515, 10.1016/0092-8674(78)90325-2 Tecedor, 2013, CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells, J Neurosci, 33, 18065, 10.1523/JNEUROSCI.0498-13.2013 Summerford, 1998, Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions, J Virol, 72, 1438, 10.1128/JVI.72.2.1438-1445.1998 Perabo, 2006, Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism, J Virol, 80, 7265, 10.1128/JVI.00076-06 Kern, 2003, Identification of a heparin-binding motif on adeno-associated virus type 2 capsids, J Virol, 77, 11072, 10.1128/JVI.77.20.11072-11081.2003 White, 2004, Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors, Circulation, 109, 513, 10.1161/01.CIR.0000109697.68832.5D Esko, 1985, Animal cell mutants defective in glycosaminoglycan biosynthesis, Proc Natl Acad Sci USA., 82, 3197, 10.1073/pnas.82.10.3197 Esko, 1988, Tumor formation dependent on proteoglycan biosynthesis, Science, 241, 1092, 10.1126/science.3137658 Kingsley, 1986, Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant, Cell, 44, 749, 10.1016/0092-8674(86)90841-X Schultz, 2011, Clarifying lysosomal storage diseases, Trends Neurosci, 34, 401, 10.1016/j.tins.2011.05.006 Muenzer, 2011, Overview of the mucopolysaccharidoses, Rheumatology (Oxford), 50 (suppl. 5), v4, 10.1093/rheumatology/ker394 Liu, 2005, Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors, J Neurosci, 25, 9321, 10.1523/JNEUROSCI.2936-05.2005 Chen, 2012, Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease, Mol Ther, 20, 1393, 10.1038/mt.2012.100 Gandhi, 2008, The structure of glycosaminoglycans and their interactions with proteins, Chem Biol Drug Des, 72, 455, 10.1111/j.1747-0285.2008.00741.x Zimmermann, 2008, Extracellular matrix of the central nervous system: from neglect to challenge, Histochem Cell Biol., 130, 635, 10.1007/s00418-008-0485-9 Pasqualini, 1996, Organ targeting in vivo using phage display peptide libraries, Nature, 380, 364, 10.1038/380364a0 Rajotte, 1998, Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display, J Clin Invest, 102, 430, 10.1172/JCI3008 Arap, 2002, Steps toward mapping the human vasculature by phage display, Nat Med, 8, 121, 10.1038/nm0202-121 Misinzo, 2006, Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells, J Virol, 80, 3487, 10.1128/JVI.80.7.3487-3494.2006 Bergefall, 2005, Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells, J Biol Chem., 280, 32193, 10.1074/jbc.M503645200 Argyris, 2003, Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts, J Virol, 77, 12140, 10.1128/JVI.77.22.12140-12151.2003 Sawada, 2011, A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matrices, Fibrogenesis Tissue Repair, 4, 7, 10.1186/1755-1536-4-7 Pajusola, 2002, Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells, J Virol, 76, 11530, 10.1128/JVI.76.22.11530-11540.2002 Summerford, 1999, AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection, Nat Med, 5, 78, 10.1038/4768 Holley, 2011, Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking a-l-iduronidase, J Biol Chem., 286, 37515, 10.1074/jbc.M111.287474 Gray, 2013, Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates, Gene Ther, 20, 450, 10.1038/gt.2012.101 Keiser, 2011, Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells, Hum Gene Ther, 22, 1433, 10.1089/hum.2011.044 Kaminsky, 2012, Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction, Mol Ther, 20, 972, 10.1038/mt.2011.295 Naumer, 2012, Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction, J Gen Virol, 93, 2131, 10.1099/vir.0.044735-0 Bobardt, 2004, Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion, J Virol, 78, 6567, 10.1128/JVI.78.12.6567-6584.2004 Yamamoto, 2005, Proteoglycans predominantly synthesized by human brain microvascular endothelial cells in culture are perlecan and biglycan, J Health Sci, 51, 576, 10.1248/jhs.51.576 Awano, 2006, A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis, Mol Genet Metab, 89, 254, 10.1016/j.ymgme.2006.02.016 Urabe, 2002, Insect cells as a factory to produce adeno-associated virus type 2 vectors, Hum Gene Ther, 13, 1935, 10.1089/10430340260355347 Smith, 2009, A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells, Mol Ther, 17, 1888, 10.1038/mt.2009.128 Farndale, 1986, Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue, Biochim Biophys Acta, 883, 173, 10.1016/0304-4165(86)90306-5 Song, 2003, Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins, In Vitro Cell Dev Biol Anim, 39, 313, 10.1290/1543-706X(2003)039<0313:COMBME>2.0.CO;2